$ZVIA

Zevia PBC (ZVIA): Submission of Matters to a Vote of Security Holders

Zevia PBC (ZVIA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. zvia20260612_8k.htm false 0001854139 0001854139 2026-06-10 2026-06-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Repo

Original reporting
Published Jun 15, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ZVIA
Neutral
high confidence
Mentioned
$ZVIA
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ZVIANeutralLow
01

Why it matters

The disclosure confirms board director elections and ratification of Deloitte & Touche as independent auditor for fiscal year ending Dec. 31, 2026; it does not include financial results or strategic changes.

02

Market read

Primarily governance housekeeping; not a catalyst for trading beyond any short-lived reaction to unusual vote dynamics (not evidenced here).

03

What to watch

Traders may instead focus on any concurrent filings (e.g., earnings, financing, or material contracts) not present in this 8-K.

Relevance 6/10Novelty 2/10Timing: Filed June 15, 2026 for June 10, 2026 annual meeting results

Background

The article is an SEC Form 8-K (Item 5.07) summarizing matters submitted to stockholders at Zevia’s 2026 Annual Meeting.

Company-level read

Ticker impact

$ZVIANeutralHigh confidence
Context

Zevia filed an 8-K reporting June 10, 2026 annual meeting vote results, including election of two directors and Deloitte ratification.

Expected impact

Low likelihood of a sustained price move based solely on these vote tallies.

Evidence & confidence

The filing discloses governance vote results (board seats and auditor ratification) without any new financial guidance, transactions, or regulatory action.

Market effects

No sector-level signal; auditor ratification and director elections are not indicative of operating changes.

None indicated beyond routine US-listed governance reporting.

None indicated.

Counterpoint

If vote outcomes were unusually contested, it could hint at governance dissatisfaction, but the filing provides no qualitative context beyond counts.

Key entities

  • Zevia PBC

    US-listed company whose annual meeting vote results are reported in the 8-K.

  • Deloitte & Touche LLP

    Independent registered public accounting firm ratified for fiscal year ending Dec. 31, 2026.

  • Suzanne S. Ginestro

    Elected Class II board member (vote totals reported).

  • David J. Lee

    Elected Class II board member (vote totals reported).

Related articles

$ZVIAHigh

Zevia PBC (ZVIA): Results of Operations and Financial Condition

Zevia PBC (ZVIA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_974482.htm EXHIBIT 99.1 ex_974482.htm Exhibit 99.1 Zevia Announces Second Quarter 2026 Results Net Sales at the High End of Outlook; Adjusted EBITDA Exceeds Outlook LOS ANGELES – August 5, 2026 (BUSINESS WIRE) – Zevia PBC (“Zevia” or the “Company”) (NYSE: ZVIA), the

$ZVIAMedAI 8/10

Zevia Appoints Brian Bousley as Chief Commercial Officer

Zevia PBC (NYSE: ZVIA) appointed Brian Bousley as Executive Vice President and Chief Commercial Officer, effective immediately. He will lead sales, distribution and category management, reporting to CEO Amy Taylor. Zevia said Bousley brings 25+ years in beverages, including CCO roles at Yerba Madre and prior leadership at Pabst Brewing and Red Bull.

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.